Biological and immunological activity of new imidazolidines against adult worms of Schistosoma mansoni
- 4 May 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Zeitschrift für Parasitenkunde
- Vol. 107 (3), 531-538
- https://doi.org/10.1007/s00436-010-1886-y
Abstract
The only drug available for treating schistosomiasis is praziquantel, however there are already reports of resistance to its use in treatment, making it necessary to search and develop new compounds to combat schistosomiasis. We tested, in vitro, two new products, Laboratório de Planejamento de Síntese de Fármacos (LPSF)/5-(4-chloro-benzylidene-3-(4-nitrebenzyl)-4-thioxo-imidazolidin-2-one (RZS-2) and LPSF/5-(4-fluoride-benzylidene-3-(4-nitrebenzyl)-4-thioxo-imidazolidin-2-one (RZS-5) imidazolidines, against adult worms of Schistosoma mansoni. Efficacy and safety of these compounds were analyzed through IC50 cytotoxicity, immune response and cell viability tests. At different concentrations ranging from 40–640 µM, the imidazolidines produced motor abnormalities, inhibition of pairing and oviposition and mortality within 24 h at the higher concentrations. Although not triggering changes in IFN-γ and IL-10, LPSF/RZS-2 and LPSF/RZS-5 induced production of nitric oxide and showed similar behavior to praziquantel in the cell death test.Keywords
This publication has 32 references indexed in Scilit:
- Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoniMolecular and Biochemical Parasitology, 2009
- Structure Mechanism Insights and the Role of Nitric Oxide Donation Guide the Development of Oxadiazole-2-Oxides as Therapeutic Agents against SchistosomiasisJournal of Medicinal Chemistry, 2009
- Nitric Oxide-Releasing Compounds Inhibit the Production of Interleukin-2, -4 and -10 in Activated Human LymphocytesBasic & Clinical Pharmacology & Toxicology, 2008
- Identification of oxadiazoles as new drug leads for the control of schistosomiasisNature Medicine, 2008
- Imidazolidines as new anti-Trypanosoma cruzi agents: Biological evaluation and structure–activity relationshipsBioorganic & Medicinal Chemistry, 2008
- Parasite infections revisitedDevelopmental & Comparative Immunology, 2005
- Immunization with cytoplasmic repetitive antigen and flagellar repetitive antigen ofTrypanosoma cruzistimulates a cellular immune response in miceParasitology, 2004
- Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatmentInternational Journal for Parasitology, 2004
- Immunity to helminths: Ready to tip the biochemical balance?Parasitology Today, 1992
- Effects of Praziquantel on Different Developmental Stages of Schistosoma mansoni in Vitro and in VivoThe Journal of Infectious Diseases, 1985